Back to Search
Start Over
Cyclophosphamide and methotrexate in Susac's Syndrome: a successful sequential therapy in a case with involvement of the cerebellum.
- Source :
-
Clinical rheumatology [Clin Rheumatol] 2015 Jun; Vol. 34 (6), pp. 1149-52. Date of Electronic Publication: 2014 May 03. - Publication Year :
- 2015
-
Abstract
- Susac's Syndrome (SS) is a rare disease with unknown aetiology due to a microangiopathy affecting the precapillary arterioles of the brain, retina, cochlea and semicircular canals. Neurological manifestations, visual dysfunction and hearing loss represent the classical clinical triad of SS. Diagnosis is confirmed by laboratory investigations, neuroimaging findings, fluoroangiography and inner-ear studies. An early treatment with steroids and immunosuppressors limits the sequelae of disease. We report a case of SS in which the clinical triad occurred in a very short period of time. Brain MRI showed the involvement of cerebellum, this representing a rare neuroradiological finding in SS. A full remission of disease was obtained by using corticosteroids and cyclophosphamide in the acute-subacute phase and methotrexate as maintenance therapy. This latter has never been used before in SS.
- Subjects :
- Brain pathology
Cerebellar Diseases diagnosis
Cerebellar Diseases etiology
Cerebellum pathology
Humans
Magnetic Resonance Imaging
Male
Susac Syndrome complications
Susac Syndrome diagnosis
Young Adult
Cerebellar Diseases drug therapy
Cyclophosphamide therapeutic use
Immunosuppressive Agents therapeutic use
Methotrexate therapeutic use
Susac Syndrome drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1434-9949
- Volume :
- 34
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Clinical rheumatology
- Publication Type :
- Academic Journal
- Accession number :
- 24794491
- Full Text :
- https://doi.org/10.1007/s10067-014-2638-7